Search results for "Quality by Design"

showing 4 items of 4 documents

Novel insights into excipient effects on the biopharmaceutics of APIs from different BCS classes: Lactose in solid oral dosage forms

2014

Excipients encompass a wide range of properties that are of importance for the resulting drug product. Regulatory guidelines on biowaivers for immediate release formulations require an in depth understanding of the biopharmaceutic effects of excipients in order to establish bioequivalence between two different products carrying the same API based on dissolution tests alone. This paper describes a new approach in evaluating biopharmaceutic excipient effects. Actually used quantities of a model excipient, lactose, formulated in combination with APIs from different BCS classes were evaluated. The results suggest that companies use different (relative) amounts depending on the characteristics o…

ChromatographyDrug CompoundingBiopharmaceuticsAdministration OralPharmaceutical ScienceExcipientLactoseBioequivalenceQuality by DesignDosage formBiopharmaceuticsExcipientschemistry.chemical_compoundchemistrymedicineHumansDrug productImmediate releaseLactosemedicine.drugEuropean Journal of Pharmaceutical Sciences
researchProduct

The Biopharmaceutics Classification System: Subclasses for in vivo predictive dissolution (IPD) methodology and IVIVC

2013

The Biopharmaceutics Classification System (BCS) has found widespread utility in drug discovery, product development and drug product regulatory sciences. The classification scheme captures the two most significant factors influencing oral drug absorption; solubility and intestinal permeability and it has proven to be a very useful and a widely accepted starting point for drug product development and drug product regulation. The mechanistic base of the BCS approach has, no doubt, contributed to its wide spread acceptance and utility. Nevertheless, underneath the simplicity of BCS are many detailed complexities, both in vitro and in vivo which must be evaluated and investigated for any given…

Drugmedia_common.quotation_subjectAdministration OralPharmaceutical ScienceComputational biologyPharmacologyModels BiologicalPermeabilityArticleIntestinal absorptionQuality by DesignDosage formBiopharmaceuticsIVIVCIn vivoTerminology as TopicAnimalsHumansTechnology PharmaceuticalComputer SimulationPharmacokineticsIntestinal Mucosamedia_commonChemistryBiopharmaceuticsReproducibility of ResultsHydrogen-Ion ConcentrationBiopharmaceutics Classification SystemIntestinal AbsorptionPharmaceutical PreparationsSolubilityEuropean Journal of Pharmaceutical Sciences
researchProduct

Role of continuous moisture profile monitoring by inline NIR spectroscopy during fluid bed granulation of an Enalapril formulation

2010

Granulation and tableting are closely related process steps in the supply chain of pharmaceutical products. Even today, these steps are still optimized independently by trial and error. On the framework of a process analytical technology approach, these processes were evaluated in an integrated approach. Enalapril maleate is a low-dose drug substance with poor granulating and tableting behavior. In order to verify how granulation influences tableting properties, different granulation experiments were performed.Granulation experiments with fast spraying rate and fast drying as well as fast spraying rate and slow drying, and also combinations of both were run. The obtained granules were then …

Materials scienceDrug CompoundingProcess analytical technologyPharmaceutical ScienceAngiotensin-Converting Enzyme InhibitorsIndentation hardnessQuality by DesignPlacebosGranulationTabletingEnalaprilHardnessDrug DiscoveryDesiccationParticle SizeProcess engineeringFluid Bed GranulationPharmacologySpectroscopy Near-InfraredMoisturebusiness.industryOrganic ChemistryNear-infrared spectroscopyWaterbusinessTabletsDrug Development and Industrial Pharmacy
researchProduct

Oral biopharmaceutics tools – Time for a new initiative – An introduction to the IMI project OrBiTo

2013

OrBiTo is a new European project within the IMI programme in the area of oral biopharmaceutics tools that includes world leading scientists from nine European universities, one regulatory agency, one non-profit research organization, four SMEs together with scientists from twelve pharmaceutical companies. The OrBiTo project will address key gaps in our knowledge of gastrointestinal (GI) drug absorption and deliver a framework for rational application of predictive biopharmaceutics tools for oral drug delivery. This will be achieved through novel prospective investigations to define new methodologies as well as refinement of existing tools. Extensive validation of novel and existing biopharm…

Physiologically based pharmacokinetic modellingComputer scienceProcess (engineering)Chemistry Pharmaceuticalmedia_common.quotation_subjectAdministration OralPharmaceutical SciencePharmacologyModels BiologicalPermeabilityQuality by DesignBiopharmaceuticsAnimalsHumansComputer SimulationPharmacokineticsQuality (business)Product (category theory)Program Developmentmedia_commonDosage FormsActive ingredientbusiness.industryBiopharmaceuticsGastrointestinal TractEngineering managementIntestinal AbsorptionPharmaceutical PreparationsSolubilityNew product developmentbusinessEuropean Journal of Pharmaceutical Sciences
researchProduct